STAAR Surgical Company
STAA
$25.26
-$0.61-2.36%
NASDAQ
| 06/27/2025 | 03/28/2025 | 12/27/2024 | 09/27/2024 | 06/28/2024 | |
|---|---|---|---|---|---|
| Revenue | 224.45M | 279.13M | 313.90M | 341.22M | 332.94M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 224.45M | 279.13M | 313.90M | 341.22M | 332.94M |
| Cost of Revenue | 63.51M | 72.58M | 74.32M | 72.57M | 69.13M |
| Gross Profit | 160.94M | 206.55M | 239.58M | 268.66M | 263.81M |
| SG&A Expenses | 191.91M | 199.30M | 200.14M | 190.69M | 188.27M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 305.88M | 323.95M | 326.25M | 313.87M | 304.99M |
| Operating Income | -81.43M | -44.81M | -12.35M | 27.36M | 27.95M |
| Income Before Tax | -97.58M | -61.33M | -9.05M | 35.02M | 28.61M |
| Income Tax Expenses | -2.31M | 9.75M | 11.16M | 13.25M | 12.00M |
| Earnings from Continuing Operations | -95.27 | -71.08 | -20.21 | 21.78 | 16.61 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -95.27M | -71.08M | -20.21M | 21.78M | 16.61M |
| EBIT | -81.43M | -44.81M | -12.35M | 27.36M | 27.95M |
| EBITDA | -72.99M | -36.82M | -5.46M | 33.09M | 33.27M |
| EPS Basic | -1.93 | -1.44 | -0.41 | 0.44 | 0.34 |
| Normalized Basic EPS | -0.88 | -0.49 | -0.11 | 0.46 | 0.38 |
| EPS Diluted | -1.93 | -1.44 | -0.41 | 0.44 | 0.34 |
| Normalized Diluted EPS | -0.88 | -0.49 | -0.12 | 0.46 | 0.38 |
| Average Basic Shares Outstanding | 197.33M | 196.94M | 196.50M | 196.05M | 195.46M |
| Average Diluted Shares Outstanding | 197.86M | 198.15M | 197.72M | 197.69M | 197.33M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |